| Trial registration number
|
IRCT20181208041886N3 |
Full text link
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/51633
|
First author
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Seyed Amir Razavian Ardehali
|
Contact
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
info@abidipharma.com
|
Registration date
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2020-12-22
|
Recruitment status
Last imported at : May 22, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Every patient with diagnosis of COVID-19
Mild, moderate and severe stage of the disease
|
Exclusion criteria
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
No complete consent and compliace of the patient for study
Follow up of the patient not be possible
The age below 15 years old
Rifampin and Phenobarbital consumers
|
Number of arms
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Abidi Pharmaceutical company
|
Inclusion age min
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
15
|
Inclusion age max
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
60
|
primary outcome
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Discontinuation of fever
Decreased Respiratory Rate
Decreased Cough
Evaluation of blood O2 Saturation
|
Notes
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : Dec. 23, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 816, "treatment_name": "Montelukast", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|